Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
21.44
-0.02 (-0.09%)
Jul 22, 2025, 2:45 PM CST
SHE:300653 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 66.59 | 116.84 | 76.58 | 82.49 | 126.49 | 193.26 | Upgrade |
Trading Asset Securities | 594.37 | 505.43 | 598.61 | 534.21 | 445.18 | 251.55 | Upgrade |
Cash & Short-Term Investments | 660.96 | 622.27 | 675.19 | 616.7 | 571.67 | 444.81 | Upgrade |
Cash Growth | -5.97% | -7.84% | 9.48% | 7.88% | 28.52% | -1.85% | Upgrade |
Accounts Receivable | 52.83 | 50.77 | 53.6 | 46.85 | 46.8 | 54.56 | Upgrade |
Other Receivables | 2.63 | 0.64 | 1.16 | 1.49 | 0.74 | 0.87 | Upgrade |
Receivables | 55.47 | 51.41 | 54.76 | 48.34 | 47.54 | 55.42 | Upgrade |
Inventory | 28.26 | 35.18 | 36.72 | 40.69 | 33.98 | 23.64 | Upgrade |
Other Current Assets | 4.42 | 3.84 | 3.97 | 4.27 | 10.2 | 3.2 | Upgrade |
Total Current Assets | 749.09 | 712.7 | 770.63 | 710.01 | 663.38 | 527.08 | Upgrade |
Property, Plant & Equipment | 226.07 | 230.09 | 243.43 | 228.03 | 219.79 | 234.04 | Upgrade |
Other Intangible Assets | 31.87 | 32.53 | 35.01 | 37.22 | 38.11 | 40.72 | Upgrade |
Long-Term Deferred Tax Assets | 2.24 | 2.33 | 2.78 | 2.67 | 2.24 | 2.73 | Upgrade |
Long-Term Deferred Charges | - | 0.02 | 0.26 | 0.69 | 0.87 | - | Upgrade |
Other Long-Term Assets | 2.42 | 2.45 | 1.71 | 8.29 | 4.53 | 0.96 | Upgrade |
Total Assets | 1,012 | 980.11 | 1,054 | 986.9 | 928.92 | 805.54 | Upgrade |
Accounts Payable | 16.77 | 21.82 | 39.11 | 58.88 | 70.01 | 92.27 | Upgrade |
Accrued Expenses | 10.51 | 12.27 | 15.9 | 21.92 | 23 | 11.59 | Upgrade |
Current Income Taxes Payable | 10.96 | 1.25 | 6.4 | 6.66 | - | 0.99 | Upgrade |
Current Unearned Revenue | 13.4 | 13.94 | 12.85 | 6.17 | 22.07 | 28.96 | Upgrade |
Other Current Liabilities | 34.43 | 31.51 | 15.75 | 11.98 | 10.96 | 11.14 | Upgrade |
Total Current Liabilities | 86.06 | 80.79 | 90 | 105.61 | 126.03 | 144.95 | Upgrade |
Long-Term Unearned Revenue | 4.72 | 4.87 | 9.12 | 9.96 | 10.48 | 13.87 | Upgrade |
Long-Term Deferred Tax Liabilities | 5.51 | 5.67 | 6.63 | 6.22 | 7.14 | - | Upgrade |
Total Liabilities | 96.29 | 91.33 | 105.76 | 121.8 | 143.65 | 158.82 | Upgrade |
Common Stock | 180 | 180 | 180 | 180 | 120 | 120 | Upgrade |
Additional Paid-In Capital | 169.42 | 169.42 | 169.42 | 169.42 | 229.42 | 229.42 | Upgrade |
Retained Earnings | 615.91 | 589.29 | 598.65 | 515.69 | 435.85 | 297.3 | Upgrade |
Treasury Stock | -49.92 | -49.92 | - | - | - | - | Upgrade |
Shareholders' Equity | 915.41 | 888.78 | 948.07 | 865.11 | 785.27 | 646.72 | Upgrade |
Total Liabilities & Equity | 1,012 | 980.11 | 1,054 | 986.9 | 928.92 | 805.54 | Upgrade |
Net Cash (Debt) | 660.96 | 622.27 | 675.19 | 616.7 | 571.67 | 444.81 | Upgrade |
Net Cash Growth | -5.97% | -7.84% | 9.48% | 7.88% | 28.52% | -1.85% | Upgrade |
Net Cash Per Share | 3.71 | 3.47 | 3.75 | 4.26 | 3.19 | 2.48 | Upgrade |
Filing Date Shares Outstanding | 177.64 | 177.64 | 180 | 180 | 180 | 180 | Upgrade |
Total Common Shares Outstanding | 177.64 | 177.64 | 180 | 180 | 180 | 180 | Upgrade |
Working Capital | 663.03 | 631.91 | 680.63 | 604.39 | 537.35 | 382.13 | Upgrade |
Book Value Per Share | 5.15 | 5.00 | 5.27 | 4.81 | 4.36 | 3.59 | Upgrade |
Tangible Book Value | 883.54 | 856.25 | 913.05 | 827.89 | 747.16 | 605.99 | Upgrade |
Tangible Book Value Per Share | 4.97 | 4.82 | 5.07 | 4.60 | 4.15 | 3.37 | Upgrade |
Buildings | - | 194.22 | 192.63 | 161.32 | 156.76 | 65.92 | Upgrade |
Machinery | - | 136.66 | 125.6 | 117.8 | 109.13 | 37.92 | Upgrade |
Construction In Progress | - | 1.34 | 8.09 | 14.63 | 4.35 | 166.11 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.